Advancing kidney health justice through gender-affirming care

Affiliations

¹ Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. heckenro@uab.edu.
² Department of Pediatrics, University of Washington School of Medicine; and Division of Nephrology, Seattle Children's Hospital, Seattle, WA, USA.
³ Division of Nephrology and General Internal Medicine, Duke University School of Medicine, Durham, NC, USA. Dm26@duke.edu.

Han E Eckenrode et al. Nat Rev Nephrol. 2022 Jun.

. 2022 Jun;18(6):343-344.

doi: 10.1038/s41581-022-00575-y.

¹ Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. heckenro@uab.edu.
² Department of Pediatrics, University of Washington School of Medicine; and Division of Nephrology, Seattle Children's Hospital, Seattle, WA, USA.
³ Division of Nephrology and General Internal Medicine, Duke University School of Medicine, Durham, NC, USA. Dm26@duke.edu.

No abstract available

References

1. Safer, J. D. & Tangpricha, V. Care of the transgender patient. Ann. Intern. Med. 171, ITC1–ITC16 (2019). - DOI
1. Hembree, W. C. et al. Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 102, 3869–3903 (2017). - DOI
1. Collister, D., Saad, N., Christie, E. & Ahmed, S. Providing care for transgender persons with kidney disease: a narrative review. Can. J. Kidney Health Dis. 8, 2054358120985379 (2021). - PubMed - PMC
1. Deutsch, M. B. Guidelines for the primary and gender-affirming care of transgender and gender nonbinary people. https://transcare.ucsf.edu/guidelines (2016).
1. Banks, K. et al. Blood pressure effects of gender-affirming hormone therapy in transgender and gender-diverse adults. Hypertension 77, 2066–2074 (2021). - DOI